Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Polycythemia vera is a disorder in which the bone marrow makes too many red and white blood cells and platelets. It typically affects people later in life, with symptoms of fatigue, itchiness, night ...

Official recalls have been issued for the 2015 Hyundai Sonata by the NHTSA. The complete details of all recalls are listed below, along with what they cover and the recommended solutions. Recalls ...

Kelby Vera is a senior reporter and the entertainment events lead for HuffPost’s trends team, where they dissect where entertainment, internet culture, politics and media overlap, from celebrities ...

Official recalls have been issued for the 2015 Jeep Grand Cherokee by the NHTSA. The complete details of all recalls are listed below, along with what they cover and the recommended solutions. Recalls ...

Based on market data through Oct 14, 2026, StockInvest.us rates Vera Therapeutics, Inc. (VERA) as a Strong Sell Candidate with a technical score of -6.96 on its -10 to +10 scale. The rating is ...

Medically reviewed by: Loren Berman, MDThis link will open in a new window Learn About Primary Care Pediatrics at Nemours Children's HealthThis link will open in a new window Appendicitis ...

Phlebotomy is a main treatment for polycythemia vera to reduce red blood cell levels. Hydroxyurea is used for people at high risk of blood clots to lower blood cell production. Interferon-alpha helps ...